SCHEMBL8355117

SCHEMBL8355117

O=C(NCc1ccccc1F)c1cc(C(=O)NCc2ccccc2F)ncn1

nearest known ligand 0.63

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MMP13 P45452 4/20 0.63
TP53 P04637 1/20 0.59
CACNA1G O43497 1/20 0.55
CACNA1H O95180 1/20 0.55
HPGD P15428 5/20 0.54
LMNA P02545 2/20 0.51
MEN1 O00255 1/20 0.51
KMT2A Q03164 1/20 0.51
ADORA3 P0DMS8 1/20 0.51
ADORA2A P29274 1/20 0.51
ADORA2B P29275 1/20 0.51
ADORA1 P30542 1/20 0.51
NPC1 O15118 1/20 0.50
MAOB P27338 1/20 0.50
ALDH1A1 P00352 1/20 0.50
MAPT P10636 1/20 0.50
TSHR P16473 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5213150 0.83 HPGD (0.57) TP53CACNA1GCACNA1HHPGDLMNA
Picolinic Acid Fluorobenzylamide SCHEMBL27812819 0.82 TSHR (0.60) TP53CACNA1GCACNA1HHPGDLMNA
SCHEMBL20804370 0.79 HPGD (0.67) TP53HPGDLMNAMEN1KMT2A
SCHEMBL8358830 0.76 MMP13 (0.77) MMP13CACNA1GCACNA1HMAOB
SCHEMBL2914008 0.76 HPGD (0.65) HPGDLMNANPC1ALDH1A1MAPT
SCHEMBL11118544 0.75 TP53 (0.52) TP53CACNA1GCACNA1HHPGDLMNA
SCHEMBL8358839 0.75 MMP13 (0.71) MMP13TP53LMNAMEN1KMT2A
SCHEMBL8358829 0.75 MMP13 (0.70) MMP13HPGDLMNAADORA3ADORA2A
SCHEMBL7013158 0.74 LMNA (0.53) TP53CACNA1GCACNA1HHPGDLMNA
SCHEMBL7013155 0.74 LMNA (0.53) TP53CACNA1GCACNA1HHPGDLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1455790-B1 USE OF PYRIDINE-2,4-DICARBOXYLIC ACID DIAMIDES AND OF PYRIMIDINE-4,6-DICARBOXYLIC ACID DIAMIDES FOR SELECTIVE COLLAGENASE INHIBITION SANOFI AVENTIS DEUTSCHLAND (DE) 2008-03-26 EP disclosed
WO-2003049738-A1 USE OF PYRIDINE-2,4-DICARBOXYLIC ACID DIAMIDES AND OF PYRIMIDINE-4,6-DICARBOXYLIC ACID DIAMIDES FOR SELECTIVE COLLAGENASE INHIBITION AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2003-06-19 WO disclosed